Madrigal Pharmaceuticals
Parth Patel, PhD, MS, is an accomplished professional in the fields of AI and data science, currently serving as Executive Director at Madrigal Pharmaceuticals. With a strong background in research and analytics, Parth has held key positions including Director of Data Sciences at Illumina and Lead Research Scientist in Population Analytics at The Janssen Pharmaceutical Companies of Johnson & Johnson. Additionally, Parth contributes as a mentor for the UD-LEAP program at the University of Delaware, where Parth also completed a Doctor of Philosophy (Ph.D.) in Bioinformatics and Systems Biology. Prior academic achievements include obtaining a Master of Science in Computer Science from Delaware State University.
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.